Synopsis:
The survival of cochlear spiral ganglion neurons was increased in mice with kanamycin ototoxicity whose cochlea were micro-injected with AAV1-anti-miR204, which suggested that anti-miR204 could be a potential therapeutic strategy in sensorineural hearing loss.